Product Overview
The BioComposite TransFix provides strong, reproducible cross pin fixation of soft tissue grafts while allowing controlled, osteoconductive degradation. The BioComposite TransFix is comprised of 30% biphasic calcium phosphate and 70% PLDLA. (https://www.arthrex.com)
